To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Triamcinolone vs Tetracosactide for Chronic Rotator Cuff Tendinitis

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
September 2025

Triamcinolone vs Tetracosactide for Chronic Rotator Cuff Tendinitis

Vol: 307| Issue: 9| Number:50| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

The comparison of the efficacy of intramuscular tetracosactide and subacromial triamcinolone injection in rotator cuff tendinitis: a randomized trial.

Rheumatol Adv Pract . 2024 Dec 20;9(1):rkae150. d

Contributing Authors:
AH Orandi A Mansour N Bagheri H Majedi SA Emami Meibodi SK Pestehei P Saberian

Synopsis

Eighty-six patients with chronic RCT were randomized to receive subacromial triamcinolone acetonide 40 mg (n=43) or IM tetracosactide 1 mg (n=43). The primary outcome was change in pain (VAS) at 4 weeks; secondary outcomes included Constant–Murley (CM) functional score and categorical VAS severity. Outcomes were assessed at baseline and 4 weeks. Overall, the results showed larger pain reduction wi...

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue